Latest filing published 18 Dec 2015 for MARRONE BIO INNOVATIONS INC.
No signal scores available.
Not enough history yet: 0 closed purchases, at least 2 are needed.
Filings by Shaugn Stanley span 2 companies, the busiest being Thomas Weisel Partners Group, Inc. and Marrone Bio Innovations Inc. We count 6 filings; the first trade dates from 22 May 2008 and the latest from 17 December 2015.
The open-market record is one-sided, with 1 purchase worth €62k and not one sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 1 share grant and 3 option exercises.
The record was last updated on 18 December 2015 with a share grant in Marrone Bio Innovations Inc. The clock since the last published purchase (23 May 2008) now reads 6,728 days. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations